These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33515532)

  • 1. Targeting signal pathways triggered by cyclic peptides in cancer: Current trends and future challenges.
    Yang Y; Mao H; Chen L; Li L
    Arch Biochem Biophys; 2021 Apr; 701():108776. PubMed ID: 33515532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic Peptides for the Treatment of Cancers: A Review.
    Ramadhani D; Maharani R; Gazzali AM; Muchtaridi M
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Challenges of Cyclic Peptides for Immunomodulation.
    Jiang X; Gao L; Li Z; Shen Y; Lin ZH
    Curr Protein Pept Sci; 2024; 25(5):353-375. PubMed ID: 37990433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicyclic Peptides as Scaffolds for the Development of Tumor Targeting Agents.
    Loktev A; Haberkorn U; Mier W
    Curr Med Chem; 2017; 24(20):2141-2155. PubMed ID: 28302013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Diversity and Biological Activities of Fungal Cyclic Peptides, Excluding Cyclodipeptides.
    Wang X; Lin M; Xu D; Lai D; Zhou L
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29186926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances in Small Peptides of Marine Origin in Cancer Therapy.
    Zhang QT; Liu ZD; Wang Z; Wang T; Wang N; Wang N; Zhang B; Zhao YF
    Mar Drugs; 2021 Feb; 19(2):. PubMed ID: 33669851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting STEAP1 Protein in Human Cancer: Current Trends and Future Challenges.
    Barroca-Ferreira J; Pais JP; Santos MM; Goncalves AM; Gomes IM; Sousa I; Rocha SM; Passarinha LA; Maia CJ
    Curr Cancer Drug Targets; 2018; 18(3):222-230. PubMed ID: 28460619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology.
    Tornesello AL; Buonaguro L; Tornesello ML; Buonaguro FM
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28767081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A gold mine for drug discovery: Strategies to develop cyclic peptides into therapies.
    Jing X; Jin K
    Med Res Rev; 2020 Mar; 40(2):753-810. PubMed ID: 31599007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolytically Stable Cyclic Decapeptide for Breast Cancer Cell Targeting.
    Raghuwanshi Y; Etayash H; Soudy R; Paiva I; Lavasanifar A; Kaur K
    J Med Chem; 2017 Jun; 60(12):4893-4903. PubMed ID: 28520410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Cyclopeptides as Anticancer Agents in the Last 20 Years.
    Zhang JN; Xia YX; Zhang HJ
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural Cyclic Peptides as an Attractive Modality for Therapeutics: A Mini Review.
    Abdalla MA; McGaw LJ
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30127265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioconjugation of Cyclometalated Gold(III) Lipoic Acid Fragments to Linear and Cyclic Breast Cancer Targeting Peptides.
    Śmiłowicz D; Slootweg JC; Metzler-Nolte N
    Mol Pharm; 2019 Nov; 16(11):4572-4581. PubMed ID: 31596097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marine Depsipeptides as Promising Pharmacotherapeutic Agents.
    Rangel M; de Santana CJ; Pinheiro A; Dos Anjos L; Barth T; Pires OR; Fontes W; Castro MS
    Curr Protein Pept Sci; 2017; 18(1):72-91. PubMed ID: 27226199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flexible or fixed: a comparative review of linear and cyclic cancer-targeting peptides.
    Roxin Á; Zheng G
    Future Med Chem; 2012 Aug; 4(12):1601-18. PubMed ID: 22917248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic peptides as potential therapeutic agents for skin disorders.
    Namjoshi S; Benson HA
    Biopolymers; 2010; 94(5):673-80. PubMed ID: 20564043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin analogs for diagnosis and treatment of cancer.
    Weckbecker G; Raulf F; Stolz B; Bruns C
    Pharmacol Ther; 1993 Nov; 60(2):245-64. PubMed ID: 7912834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lanreotide++: a new therapeutic option in acromegaly].
    Díez JJ
    Med Clin (Barc); 1996 Sep; 107(7):257-69. PubMed ID: 8975096
    [No Abstract]   [Full Text] [Related]  

  • 19. Developing cyclic peptide-based drug candidates: an overview.
    Jin K
    Future Med Chem; 2020 Oct; 12(19):1687-1690. PubMed ID: 32972246
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth.
    Pacifico S; Santucci M; Luciani R; Saxena P; Linciano P; Ponterini G; Lauriola A; D'Arca D; Marverti G; Guerrini R; Costi MP
    Molecules; 2019 Sep; 24(19):. PubMed ID: 31561530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.